Cosmetic Injectables

Patient name: Chloe Elizabeth Vance

Medical history: Hypothyroidism, episodic migraine without aura. Nil history of keloid scarring, neuromuscular disorders, or autoimmune disease. Not pregnant or breastfeeding.

Allergies: Penicillin (urticaria). Nil known allergies to lidocaine or bee/wasp stings.

Medications: levothyroxine (Oroxine®) 100 mcg PO daily, sumatriptan (Imigran®) 50 mg PO PRN. Ceased fish oil 7 days prior.

Concerns with ageing: Deepening dynamic glabellar and forehead rhytids, static periorbital lines, and mild mid-face volume loss contributing to a fatigued appearance.

Injectable plan: Anti-wrinkle injections to upper face (glabella, frontalis, orbicularis oculi) today. Staged hyaluronic acid dermal filler to bilateral zygomatic arches at future visit.

Injectables today: incobotulinumtoxinA (Xeomin®) total 46 units IM (reconstituted with 2.5 mL bacteriostatic 0.9% NaCl; Lot: X84920, Exp: 11/2026): glabella 20 units across 5 sites, frontalis 10 units across 5 sites, bilateral orbicularis oculi 16 units (8 units per side across 3 sites).

Cost: $598.00 AUD

Treatment plan: Review in 14 days to assess toxin efficacy and symmetry. Proceed with 1 mL hyaluronic acid filler to mid-face in 4 weeks if desired. Repeat upper face toxin every 3–4 months PRN.

After care: Remain upright for 4 hours; avoid rubbing/massaging treated areas, strenuous exercise, saunas, and alcohol for 24 hours. Avoid active cosmeceuticals (retinoids, AHAs) for 24 hours and facials/microdermabrasion for 2 weeks. Contact clinic immediately if signs of ptosis, visual changes, or severe headache occur.